GAST and gastric cancer: Therefore, the authors believe that long-term use of PPIs can lead to an increase in gastrin, the formation of hypergastrinemia, and mediate the development of gastric cancer or gastric neuroendocrine tumors via the gastrin-ECL cell axis.